Q2FY26
Exagen Q2FY26 Results: What Makes This Revenue Record Worth Celebrating?
Exagen Q2FY26 Results show record revenue of $19.9 million, nearing EBITDA breakeven. What does this mean for investors?
Exagen Q2FY26 Results show record revenue of $19.9 million, nearing EBITDA breakeven. What does this mean for investors?